Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Encephalomyelitis Vaccines
Research on encephalomyelitis vaccines discussed by Y. Uemura and co-researchers
June 25th, 2008
New research, 'The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis,' is the subject of a report. "Experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), can be induced by the immunization of mice with myelin antigens in the form of myelin oligodendrocyte glycoprotein (MOG). Macrophage colony-stimulating factor (M-CSF) is required for the development of individual mononuclear phagocyte populations and is involved in the immune response," scientists in Gunma, Japan report. "We previously reported that Ki20227...
Source: Vaccine Weekly (2008-06-25)
|
